In This Article:
As the U.S. stock market shows signs of recovery, with major indices like the Dow Jones and Nasdaq rebounding from recent downturns, investors are keenly exploring diverse opportunities. Penny stocks, though often seen as a relic of past investment strategies, remain relevant by offering potential growth at accessible price points. In this article, we explore several penny stocks that exhibit strong financial foundations and could present intriguing prospects for those seeking investments in smaller or newer companies.
Top 10 Penny Stocks In The United States
Name | Share Price | Market Cap | Financial Health Rating |
Inter & Co (NasdaqGS:INTR) | $4.11 | $1.85B | ★★★★☆☆ |
QuantaSing Group (NasdaqGM:QSG) | $3.08 | $110.4M | ★★★★★★ |
BAB (OTCPK:BABB) | $0.838 | $5.59M | ★★★★★★ |
Kiora Pharmaceuticals (NasdaqCM:KPRX) | $3.58 | $9.9M | ★★★★★★ |
ZTEST Electronics (OTCPK:ZTST.F) | $0.3267 | $10.67M | ★★★★★★ |
Golden Growers Cooperative (OTCPK:GGRO.U) | $4.50 | $67.38M | ★★★★★★ |
BTCS (NasdaqCM:BTCS) | $2.62 | $42.86M | ★★★★★★ |
Smith Micro Software (NasdaqCM:SMSI) | $1.45 | $23.24M | ★★★★★☆ |
CBAK Energy Technology (NasdaqCM:CBAT) | $1.01 | $84.54M | ★★★★★☆ |
Safe Bulkers (NYSE:SB) | $3.66 | $381.2M | ★★★★☆☆ |
Click here to see the full list of 726 stocks from our US Penny Stocks screener.
Underneath we present a selection of stocks filtered out by our screen.
Lifeward
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Lifeward Ltd. is a medical device company focused on designing, developing, and commercializing technologies to enhance mobility and wellness for individuals with physical and neurological conditions globally, with a market cap of $15.24 million.
Operations: The company generates revenue of $25.00 million from its Medical Products segment.
Market Cap: $15.24M
Lifeward Ltd., a medical device company, has shown significant revenue growth, reporting US$18.12 million for the first nine months of 2024 compared to US$6.97 million the previous year. Despite this, it remains unprofitable with a net loss of US$13.66 million for the same period. The company's recent strategic moves include streamlining U.S. operations and appointing Robert J. Marshall Jr., an experienced finance professional, as a director and Chairman of the Audit Committee. Lifeward's short-term assets exceed its liabilities, but it faces challenges with high share volatility and limited cash runway under one year without debt obligations.
-
Take a closer look at Lifeward's potential here in our financial health report.
-
Evaluate Lifeward's prospects by accessing our earnings growth report.
Kaltura
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Kaltura, Inc. offers software-as-a-service (SaaS) and platform-as-a-service (PaaS) solutions globally, with a market cap of approximately $329.33 million.